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Abstract
Background: In order to establish a successful infection in the human host, the malaria parasite
Plasmodium falciparum must establish interactions with a variety of human proteins on the surface
of different cell types, as well as with proteins inside the host cells. To better understand this aspect
of malaria pathogenesis, a study was conducted with the goal of identifying interactions between
proteins of the parasite and those of its human host.
Methods: A modified yeast two-hybrid methodology that preferentially selects protein fragments
that can be expressed in yeast was used to conduct high-throughput screens with P. falciparum
protein fragments against human liver and cerebellum libraries. The resulting dataset was analyzed
to exclude interactions that are not likely to occur in the human host during infection.
Results: An initial set of 2,200 interactions was curated to remove proteins that are unlikely to
play a role in pathogenesis based on their annotation or localization, and proteins that behave
promiscuously in the two-hybrid assay, resulting in a final dataset of 456 interactions. A cluster that
implicates binding between P. falciparum PFE1590w/ETRAMP5, a putative parasitophorous vacuole
membrane protein, and human apolipoproteins ApoA, ApoB and ApoE was selected for further
analysis. Different isoforms of ApoE, which are associated with different outcomes of malaria
infection, were shown to display differential interactions with PFE1590w.
Conclusion: A dataset of interactions between proteins of P. falciparum and those of its human
host was generated. The preferential interaction of the P. falciparum PFE1590w protein with the
human ApoE ε3 and ApoE ε4 isoforms, but not the ApoE ε2 isoform, supports the hypothesis that
ApoE genotype affects risk of malaria infection. The dataset contains other interactions of potential
relevance to disease that may identify possible vaccine candidates and drug targets.
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Background
Malaria is a devastating global disease, responsible for
approximately 500 million clinical cases and more than a
million deaths per year [1]. The most deadly form is
caused by Plasmodium falciparum, which has a complex life
cycle. The parasite is delivered to the human bloodstream
as sporozoites that develop in the salivary gland of
infected mosquitoes. These motile forms enter the liver,
transversing through several cells before establishing
themselves in a hepatocyte. Within the hepatocyte, the
parasite undergoes a large number of asexual divisions,
eventually releasing tens of thousands of merozoites that
are capable of attaching to and invading erythrocytes.
Within the erythrocyte, the parasite again divides several
times in a 48-hour timeframe, releasing 16 or more mero-
zoites that invade new erythrocytes. This intraerythrocytic
stage is responsible for the cyclic symptoms of human dis-
ease (reviewed in [2]).
As a consequence of its life cycle, P. falciparum must be
able to recognize, bind to and invade at least the two
human cell types of hepatocytes and erythrocytes. These
events are defined by particular molecular interactions.
For example, hepatocyte invasion requires binding of the
parasite's circumsporozoite surface protein to heparan
sulfate proteoglycan surface receptors [3], although other
P. falciparum proteins have been implicated in this process
[4]. Many P. falciparum proteins have been proposed to be
involved in erythrocyte invasion, and the human recep-
tors for a few of them have been characterized (for exam-
ple, EBA-175/glycophorin A and EBA-140/glycophorin C,
MSP1/band3); however, the receptors for most of the par-
asite proteins implicated in erythrocyte invasion remain
to be identified (reviewed in [5,6]).
In both hepatocytes and erythrocytes, the parasite is con-
tained in a membranous structure known as the parasito-
phorous vacuole. Within this structure, however, the
parasite is not isolated from the host cell, and must
import nutrients from the plasma and the host cell cyto-
plasm to survive [7]. Particularly in the case of erythrocyte
invasion, P. falciparum also establishes an active export of
its proteins to the cytoplasm and surface of the host cell,
where they modify the surface's structural and adhesive
properties (reviewed in [8]). The presence of parasite pro-
teins, such as PfEMP1 and other adhesins on the surface
of erythrocytes, causes these infected cells to sequester to
endothelia and placenta via interactions with surface
receptor molecules such as CD36, chondroitin sulfate A,
ICAM-1 and selectins, resulting in the evasion of these
cells from the host immune system. In addition, several
parasite proteins interact with human cytoskeletal pro-
teins; for example, PfEMP3 interacts with spectrin and
actin [9], and both RESA and KAHRP interact with spec-
trin [10,11].
Previously, a large network of interactions among the pro-
teins of P. falciparum was generated [12]. The results of a
similar high-throughput yeast two-hybrid analysis aimed
at detecting interactions between proteins of P. falciparum
and those of its human host are presented here. An initial
dataset of over 2,200 putative interactions was curated to
exclude interactions that are not likely to be relevant to
the pathogenesis of the parasite, resulting in a final dataset
of 456 interactions. Among these, a cluster of interactions
involving P. falciparum PFE1590w/ETRAMP5 and human
apolipoproteins ApoA1, ApoB and ApoE was studied fur-
ther.
Materials and methods
Library construction and high-throughput yeast two hybrid 
screens
Protocols described in [12] were used to generate libraries
of plasmids encoding P. falciparum and human protein
fragments as fusions with Gal4 domains and auxotrophic
markers to select for expression in yeast. High-throughput
yeast two-hybrid screens, selection of positive colonies,
PCR amplification and sequencing of inserts to determine
the identity of the interacting partners were also per-
formed following the techniques described in [12].
Dataset curation and filtering
Plasmodium falciparum protein annotations were down-
loaded from PlasmoDB [13] and human protein annota-
tions were downloaded from DAVID [14]. Information
was also obtained from other databases, including Gene-
Cards [15], Entrez Gene [16] and GeneDB [17]. K-cluster-
ing was performed as described in [12] and resulted in the
exclusion of human proteins with 25 or more partners (k
= 2) and P. falciparum proteins with 18 or more partners
(k = 3).
Two-hybrid retests
Plasmids were purified from the positive diploid yeast
strains identified in the high-throughput screens,
sequenced, and re-transformed into yeast. R2HMet yeast
strains expressing different P. falciparum protein fragments
as fusions with the Saccharomyces cerevisiae Gal4 DNA-
binding domain and Met2 were mated against BK100
yeast strains expressing human protein fragments as
fusions with the S. cerevisiae Gal4 activation domain and
Ura3 (or its orthologue S. pombe Ura4) [12]. For retesting
positives, diploids were selected in synthetic media lack-
ing tryptophan and leucine with or without extra adenine,
and their ability to activate the HIS3 reporter gene in the
presence of 0 to 3 mM 3-aminotriazole was tested by
streaking or serial dilution. Plates were grown at 30°C for
up to a week and scanned.Malaria Journal 2008, 7:211 http://www.malariajournal.com/content/7/1/211
Page 3 of 9
(page number not for citation purposes)
Protein extracts and western blots
Yeast extracts were prepared as described [18] and sub-
jected to electrophoresis on 4–12% NuPAGE/MOPS gels
(Invitrogen). Western blotting was performed using
standard procedures with 1:100 dilution of anti-GAL4-TA
(C-10) antibodies (Santa Cruz) and 1:5,000 dilution of
anti-actin antibodies.
Results
Filtering of a high throughput two-hybrid dataset
To identify interactions between P. falciparum and human
proteins, a modified yeast two-hybrid approach was
applied as described previously [12]. This method prefer-
entially selects for plasmids that encode fragments of pro-
teins that can be expressed in yeast, and is particularly
useful for P. falciparum proteins, which are difficult to
express in heterologous systems. DNA-binding domain
(BD) libraries of protein inserts from P. falciparum mRNA
expressed during the intraerythrocytic cycle and activation
domain (AD) libraries from human liver and cerebellum
mRNA were generated. 9,408 two-hybrid screens with
randomly chosen fragments of P. falciparum proteins were
performed against the human activation domain libraries.
Diploid yeast strains were selected and the identities of
the putative interactive partners were determined as
described [12]. These searches yielded 2,212 unique inter-
actions involving 507 P. falciparum and 986 human pro-
teins.
As with other high throughput two-hybrid studies, many
of the putative interactions identified likely do not repre-
sent bona fide binding between a parasite and human pro-
tein but correspond instead to false positives that arise in
these assays [19]. The bulk of these false positives are due
to proteins that lead to transcriptional activation in yeast
in the absence of any interaction between the proteins
encoded by the two-hybrid vectors. Such proteins can be
identified by a variety of means, including their over-rep-
resentation among the putative interactions.
In other cases, the two-hybrid results reflect proteins that
interact in the yeast assay but not in their normal in vivo
setting. For example, the initial dataset contained exam-
ples of putative interactions between two orthologous
proteins, one from P. falciparum and one from human,
indicating most likely that each of these proteins normally
homodimerizes. In other examples, a human protein was
observed to interact with the P. falciparum orthologue of
its known human protein partner. Both of these types of
interactions reflect the high degree of conservation of
these protein pairs between the two species.
Interactions more likely to be relevant to P. falciparum
pathogenesis were identified by curation of the initial
dataset, taking into account available information about
the proteins involved in the interactions. Annotated and
predicted GO classifications were considered, as well as
other functions and properties of the proteins: the pres-
ence of transmembrane domains, evidence of membrane
localization (except for nuclear membrane localization),
and classification as extracellular or secreted protein were
considered positive features. For P. falciparum proteins,
the presence of a signal peptide, evidence or prediction of
export to the host cell cytoplasm, presence in Maurer's
clefts, localization to the surface of the infected erythro-
cyte, and classification as a putative adhesin were also
considered as positive features (see PlasmoDB for data
sources). Interactions involving P. falciparum or human
proteins with likely nuclear function, mitochondrial
localization, roles in basic cellular processes (including
translation, RNA processing, protein degradation, ubiqui-
tin metabolism and nuclear/cytoplasmic transport), and
metabolic enzymes were excluded from the final dataset.
Also excluded were interactions involving P. falciparum
proteins annotated as chaperones, apicoplast or cytoskel-
eton proteins, if there was no additional evidence of their
being exported to the host cell.
In addition, a large number of apparent partners that
likely activate the two-hybrid reporter gene by mecha-
nisms that do not involve bona fide interactions were elim-
inated by a k-clustering algorithm that takes into
consideration the number of partners of each protein in
the dataset to establish thresholds for exclusion. By this
means, all proteins present as DNA-binding domain
fusions with 18 or more interactions and as activation
domain fusions with 25 or more interactions were
excluded. Putative interactions of proteins that had been
classified as promiscuous in previous large-scale yeast
two-hybrid studies of P. falciparum proteins [12] or
human proteins (unpublished data from Prolexys Phar-
maceuticals, Inc.) were also excluded.
Although these filters potentially exclude some biologi-
cally relevant interactions, the majority of the interactions
removed are most likely false positives. The resulting data-
set consists of 456 interactions, involving 203 P. falci-
parum proteins and 314 human proteins (Additional file
1), and is enriched for proteins that are likely to be at the
interface of the parasite and the host.
Interaction of P. falciparum PFE1590w with human 
apolipoproteins
A cluster of interactions between P. falciparum hypotheti-
cal protein PFE1590w and human apolipoproteins
ApoA1, ApoB and ApoE was identified from screens of the
human liver cDNA library (Additional file 1). PFE1590w
(alternatively known as etrampBLOB.1, ETRAMP5 and
antigen 22) is a protein of unknown function that belongs
to the ETRAMP (Early TRAnscribed Membrane Proteins)Malaria Journal 2008, 7:211 http://www.malariajournal.com/content/7/1/211
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or SEP (Small Exported Proteins) family of single-pass
transmembrane proteins [20,21]. Several ETRAMPs have
been shown to localize to the parasitophorous vacuole,
the membranous structure in which the parasite resides
when inside the erythrocyte and hepatocyte [21]. A trans-
fected myc-tagged version of PFE1590w localizes to the
periphery of late ring and early trophozoite-infected
erythrocytes, suggesting that, like other ETRAMPs, the
native PFE1590w could also be localized to the parasito-
phorous vacuole membrane, where it would be at the
interface between the parasite and the host cell [22]. Apol-
ipoproteins are expressed by the liver and intestine and
secreted to the plasma, where they bind cholesterol and
participate in the clearance of lipoprotein particles by
hepatocytes [23].
Four overlapping fragments of PFE1590w interacted with
15 overlapping ApoA1 fragments, 1 ApoE fragment and 3
ApoB fragments (Figure 1A). All of the PFE1590w frag-
ments contained the transmembrane domain and
extended to different extents towards the amino- and car-
boxy-termini, including variable amounts of the region of
highest amino acid complexity in the PFE1590w protein.
ApoA and ApoE belong to the same family and share
sequence and structural features, as well as common
receptors on the surface of the hepatocytes [23]. Align-
ment of the fragments of ApoA and ApoE that interacted
with PFE1590w revealed a conserved region that could be
responsible for this interaction (Figure 1B).
Plasmids encoding PFE1590w or apolipoprotein frag-
ments were purified from yeast transformants and rese-
quenced to determine both the exact starting and ending
residues of the inserts as well as the reading frame with
respect to the Gal4 DNA-binding or activation domain.
Three of the PFE1590w fragments (excluding one that was
highly similar to one of these three) were retested against
nine different apolipoprotein fragments (all the ApoB and
ApoE fragments, and five representative ApoA1 frag-
ments) by introducing plasmids back into the yeast strains
and repeating the mating and selection procedures in
small scale. This assay confirmed binding between
PFE1590w and ApoA1, ApoE and ApoB (Figure 2). The
interactions were specific, as demonstrated by the lack of
growth under selective conditions of strains carrying
PFE1590w or an apolipoprotein insert along with an
empty two-hybrid vector or one encoding for an unrelated
fusion protein.
The gene for apolipoprotein ApoE is present in human
populations as three alleles that differ only by the amino
acid residue encoded in positions 112 and 158: ApoE ε2
contains cysteine in both positions, ApoE ε3 contains
cysteine in position 112 but arginine in position 158, and
ApoE  ε4 has arginine in both positions [24]. These
changes have been associated with differences in the struc-
ture of the protein, and in turn, their function in lipid
metabolism [23]. Because the different ApoE alleles have
been implicated in the outcome of malaria infection [25-
27], the selectivity of interactions between the corre-
sponding ApoE isoforms and P. falciparum PFE1590w was
studied. To this end, full-length versions of the three alle-
Interactions between P. falciparum PFE1590w and human  apolipoproteins ApoA, ApoE and ApoB identified by high- throughput screens Figure 1
Interactions between P. falciparum PFE1590w and 
human apolipoproteins ApoA, ApoE and ApoB iden-
tified by high-throughput screens. (A) The fragments of 
PFE1590w involved in the interactions with human apolipo-
proteins are depicted above a diagram of the full-length pro-
tein, with the amino-terminal signal peptide (SP) and the 
transmembrane domain (TM) indicated. Low complexity 
regions are shown below. The human apolipoproteins that 
interacted with each PFE1590w peptide are listed to the 
right. The domain predicted by Phobius [30] to be exposed 
to the cytoplasm is shown. Numbers correspond to amino 
acid coordinates. (B) The fragments of ApoA1 and ApoE 
involved in the interactions were aligned by the MAVID/
AMAP multiple alignment server [48]. The box indicates the 
region conserved among all ApoA1 and ApoE protein frag-
ments identified in the screens.
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AMAP (2.0) multiple sequence alignment
ApoA1aa29to195       -------QSPWDRVKDLATVYVDVLKDSGRDYVSQFEG-SALGKQLNLKLLDNWDSVTST 52
ApoA1aa76to165       -------------------------------------------------------SVTST 5
ApoA1aa100to265      ------------------------------------------------------------
ApoA1aa127to265      ------------------------------------------------------------
ApoA1aa129to258      ------------------------------------------------------------
ApoEaa139to309       EVQAMLGQSTEELRVRLASHLRKLRKRLLRD-------ADDLQKRLAVYQAGAR------ 47
                             ..       ..              .                     . ...
ApoA1aa29to195       FSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR 112
ApoA1aa76to165       FSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR 65
ApoA1aa100to265      -------------------EKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR 41
ApoA1aa127to265      ----------------------------------------------DFQKKWQEEMELYR 14
ApoA1aa129to258      ------------------------------------------------QKKWQEEMELYR 12
ApoEaa139to309       ------------------------------------------------------------
                      .       . .          .       .       .   .                 
ApoA1aa29to195       QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRD---------------RARAHVDALRT 157
ApoA1aa76to165       QKVEPLRAELQEGARQKLHELQEKL----------------------------------- 90
ApoA1aa100to265      QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRD---------------RARAHVDALRT 86
ApoA1aa127to265      QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRD---------------RARAHVDALRT 59
ApoA1aa129to258      QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRD---------------RARAHVDALRT 57
ApoEaa139to309       -----------EGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAW------ 90
                         .  .   ***.: *  ::*:* .                       . .   .  .
ApoA1aa29to195       HLAPYSDELR-------------------------------------------------- 167
ApoA1aa76to165       ------------------------------------------------------------
ApoA1aa100to265      HLAPYSDELRQRLAARLEALKENGGAR-------LAEYHAKATEHLSTLSEKAKPALEDL 139
ApoA1aa127to265      HLAPYSDELRQRLAARLEALKENGGAR-------LAEYHAKATEHLSTLSEKAKPALEDL 112
ApoA1aa129to258      HLAPYSDELRQRLAARLEALKENGGAR-------LAEYHAKATEHLSTLSEKAKPALEDL 110
ApoEaa139to309       ---------GERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARL 141
                       .. .                                                      
ApoA1aa29to195       ------------------------------
ApoA1aa76to165       ------------------------------
ApoA1aa100to265      RQGLLPVLESFKVSFLSALEEYTKKLN--- 166
ApoA1aa127to265      RQGLLPVLESFKVSFLSALEEYTKKLN--- 139
ApoA1aa129to258      RQGLLPVLESFKVSFLSALE---------- 130
ApoEaa139to309       KSWFEPLVEDMQRQWAGLVEKVQAAVGTSA 171
                                                   
low complexity regions
PFE1590w
AMalaria Journal 2008, 7:211 http://www.malariajournal.com/content/7/1/211
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les of ApoE (ApoE ε2, ε3, and ε4) were cloned into the
Gal4 AD vector. To ensure that the interactions did not
depend on the presence of S. cerevisiae Met2 on the car-
boxy-terminus of the PFE1590w fusion protein (which is
used to select for expressed proteins in this version of the
two-hybrid assay [12]), the MET2 coding sequence was
replaced with that for glutathione S-transferase (GST).
This construct yielded a stronger growth signal in the pres-
ence of the AD-apolipoprotein hybrids than the original
one, and was, therefore, used for all further experiments.
Diploid yeast containing BD-PFE1590w (amino acids 94–
156)-GST and an AD hybrid containing either of the two
isoforms of the ApoE protein with arginine at position
158 (ApoE ε3 and ApoE ε4) grew well on selective media
(Figure 3A, right panel). In contrast, when the yeast con-
tained instead the ApoE ε2 isoform with cysteine at posi-
tion 158, much weaker growth was observed. All
transformants exhibited comparable growth on media
that does not select for protein-protein interactions (Fig-
ure 3A, left panel). The ApoE selectivity is consistent with
the results from the high-throughput screens that identi-
fied an ApoE fragment extending from residue 139 to 309
with arginine in position 158, corresponding to either the
Apo ε3 or the ε4 isoform.
To rule out the possibility that differential two-hybrid sig-
nals could result from variable expression of the three
ApoE isoforms in yeast, the levels of ApoE proteins were
assayed by Western blot. Comparable expression of the
three ApoE isoforms as AD hybrid proteins was observed
(Figure 3B, top panel), with actin expression serving as a
loading control (Figure 3B, bottom panel). Thus, these
data indicate that the interaction of PFE1590w with ApoE
proteins is dependent on the presence of arginine at posi-
tion 158 of the ApoE protein. Polymorphisms at this posi-
tion also influence the ability of ApoE to interact with
other molecules, such as lipids and the LDL receptor [23].
Discussion
Protein-protein interactions underlie the critical processes
of infectious diseases, determining the specificity, affinity
and efficiency by which pathogenic organisms are able to
invade the human host. In the case of the malaria parasite
P. falciparum, several processes that are essential to patho-
genesis depend on host-parasite interactions, such as
entry into host cells, growth and division within these
cells, and binding to the lining of vasculature. An effort to
identify such interactions was undertaken through the use
of a large-scale yeast two-hybrid screening approach. The
initial dataset of putative interactions was pared down to
456 interactions deemed most likely to be bona fide ones.
However, two-hybrid false positives remain in this pared
down set and no complementary verification of these
interactions by a biochemical approach, such as co-immu-
noprecipitation, has been carried out; thus, these interac-
tion data should be interpreted cautiously.
The interactions between P. falciparum hypothetical pro-
tein PFE1590w and human apolipoproteins ApoA1, ApoB
and ApoE were further studied and determined to be spe-
cific by yeast two-hybrid. Furthermore, the preferential
interaction of PFE1590w with the ApoE ε3 and ApoE ε4
isoforms but not the ApoE ε2 isoform was observed.
The genome of P. falciparum encodes 13 members of the
ETRAMP protein family, which are predicted to have an
amino-terminal signal peptide and a single transmem-
brane domain [21]. ETRAMPs are conserved among Plas-
modium species, although PFE1590w does not have a clear
orthologue in the rodent Plasmodium species. Unlike other
ETRAMPs, PFE1590w is abundant in negatively charged
residues, and has a 50-residue insertion rich in serines and
prolines between the signal peptide and the transmem-
brane domain, resulting in its annotation as an atypical
ETRAMP [21]. The gene encoding PFE1590w is expressed
during the intraerythrocytic cycle [21,28,29] as well as in
liver stages (Cate Speake and Patrick Duffy, personal com-
munication). A transfected myc-tagged version of
PFE1590w localizes to the periphery of the parasite in late
ring and early trophozoite-infected erythrocytes, suggest-
ing a parasitophorous vacuole membrane localization for
this protein inside the infected erythrocytes [22]. Phobius
[30], a programme that predicts the orientation of mem-
Reproducibility and specificity of the P. falciparum PFE1590w  interactions with human apolipoproteins ApoA, ApoE and  ApoB Figure 2
Reproducibility and specificity of the P. falciparum 
PFE1590w interactions with human apolipoproteins 
ApoA, ApoE and ApoB. Diploid strains expressing differ-
ent combinations of PFE1590w and human apolipoprotein 
fragments as fusion proteins were tested for their ability to 
activate the HIS3 reporter gene in the presence of 3 mM 3-
aminotriazole. The amino acid coordinates of the P. falci-
parum and human interacting protein fragments are indicated. 
Controls are strains carrying empty vectors encoding Gal4 
BD or Gal4 AD, as well as fusions of Gal4 BD-PFE1350c 
(amino acids 9 to 135) and Gal4 AD-PFC0255c (amino acids 
4 to 136), an interacting pair of P. falciparum proteins [12].Malaria Journal 2008, 7:211 http://www.malariajournal.com/content/7/1/211
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P. falciparum PFE1590w interacts differentially with ApoE isoforms ε2, ε3 and ε4 Figure 3
P. falciparum PFE1590w interacts differentially with ApoE isoforms ε2, ε3 and ε4. (A) Yeast diploids containing the 
indicated plasmids were grown to an OD660 = 1.0, serially diluted and spotted onto solid synthetic complete media missing 
tryptophan and leucine and supplemented with extra adenine (SC-T-L+Ade), and onto plates missing tryptophan, leucine and 
histidine, and incubated at 30 C for 5–7 days. (B) Proteins were extracted from yeast cells grown in SC-T-L+Ade media to an 
OD660 = 1.0, separated by gel electrophoresis and transferred onto membranes by Western blot. Fusion proteins were 
detected with antibodies directed towards the Gal4 activation domain (upper panel), and antibodies against actin were used as 
a loading control (bottom panel).
 Malaria Journal 2008, 7:211 http://www.malariajournal.com/content/7/1/211
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brane proteins, predicts that residues 136–181 are cyto-
plasmic (Figure 1A), suggesting that the carboxy-terminal
domain involved in the interactions described in this
study could be exposed to the cytoplasm of the host cell.
Since apolipoprotein-containing particles are internalized
by the hepatocyte [23], if PFE1590w also localizes to the
parasitophorous vacuole during the liver stages, the inter-
actions between PFE1590w and apolipoproteins could
take place in the hepatocyte.
The mRNA for PFE1590w has also been detected in game-
tocytes and in sporozoites [21,29], and PFE1590w pep-
tides have been detected by mass spectrometry in
trophozoites and in the membrane of the infected eryth-
rocytes [31,32]. Parasite inhibitory antibodies against
PFE1590w are present in the sera of individuals that have
suffered malaria infections, supporting the idea that
PFE1590w might be a surface protein, although it is also
possible that this immunity is a result of exposure of the
immune system of the host to the protein upon lysis of
the parasite [33]. Therefore, besides being localized to the
parasitophorous vacuole membrane, PFE1590w could be
present on the plasma membrane of the sporozoite or the
membrane of the infected red blood cell, where it could
interact with plasma apolipoproteins.
Other ETRAMPs have been shown to be involved in inter-
actions with host proteins. Plasmodium yoelii UIS3, a
rodent ETRAMP essential for parasite development during
liver stages that is orthologous to P. falciparum
PF13_0012, interacts with liver fatty-acid binding protein
(L-FABP) [34]. UIS3 localizes to the parasitophorous vac-
uole membrane within the hepatocyte [35], and binds L-
FABP via its carboxy-terminal domain, which is predicted
to be exposed to the cytoplasm of the host cell cytoplasm.
Down-regulation of L-FABP by RNAi greatly inhibits the
growth of parasites in cultured hepatoma cells, whereas
overexpression of L-FABP promotes growth [34]. An inter-
action between human L-FABP and P. falciparum
PFD0090c was observed in this study. PFD0090c is a
hypothetical protein of the pHIST family[36], and is pre-
dicted to be exported to the cytoplasm of the host cell. In
addition, PFD0090c has also been found by mass spec-
trometry on the surface of the infected erythrocyte [31].
Several lines of evidence suggest that apolipoproteins
might have a role in the pathogenesis of the malaria para-
site. First, apolipoproteins have been reported to inhibit
invasion of hepatocytes by Plasmodium  sporozoites by
competing with the most abundant protein on the surface
of sporozoites, circumsporozoite protein, for binding to
HepG2 cultured liver cells, and delaying liver-mediated
clearance of circumsporozoite protein from circulation
[37]. Second, apolipoprotein E-enriched β-very low den-
sity lipoprotein inhibits invasion of HepG2 cells by spo-
rozoites of a rodent Plasmodium species, P. berghei, and
mice with high levels of circulating apolipoproteins have
lower hepatic parasite loads. Based on this evidence, Sin-
nis et al. [37] postulated that invasion of hepatocytes by
the parasite and lipoprotein uptake by the liver share a
common mechanism that is likely mediated by binding to
heparan sulfate proteoglycans, the physiological receptors
of apolipoproteins on the surface of the hepatocytes.
Third, studies of human populations have revealed corre-
lations between the apolipoprotein E genotype of the
human host and the susceptibility to malaria infection;
although the ApoE ε3 allele is the most frequent world-
wide, the ApoE ε4 allele, which is possibly the ancestral
one, has an extremely high frequency in malaria endemic
areas, including sub-Saharan Africa and Papua New
Guinea [38,39]. In addition, Gambian children
homozygous for the ApoE ε2 allele are more likely to suf-
fer early malaria infection [25], while heterozygotes carry-
ing the ApoE ε3 and ε4 alleles are more likely to suffer
severe malaria, including cerebral malaria and severe
anaemia [26]. These apparently contradictory data are
compatible with the notion that children who suffer infec-
tions earlier in life develop protection against severe
malaria [27]. While these results are based on a small
number of individuals, they suggest that the ApoE geno-
type of the human host influences the outcome of malaria
infection. The data presented here that indicates a selec-
tive interaction between PFE1590w and ApoE alleles ε3
and ε4 is consistent with the notion that this interaction
might be related to malaria pathogenesis. It is possible
that the PFE1590w – ApoE interaction is important for
cerebral malaria and severe anaemia, and thus individuals
carrying ApoE ε3 and ε4 alleles are more likely to develop
these symptoms.
The relevance of the PFE1590w – apolipoprotein interac-
tion for the parasite's ability to infect or develop within
human host cells remains to be determined. Apolipopro-
teins are synthesized in the liver, and are cleared from cir-
culation by the liver. The interaction may be involved in
the invasion of liver cells by sporozoites, or alternatively,
the interaction could be important for the parasite's sur-
vival inside the red blood cell or the hepatocyte. As in the
case of the P. yoelii UIS3 – L-FABP interaction, PFE1590w
might be involved in the uptake of lipids, in particular
cholesterol, from the host. Toxoplasma gondii, an apicom-
plexan parasite related to P. falciparum, critically depends
on host cholesterol from low-density plasma lipoproteins
for survival, which it acquires by co-opting the host endo-
cytosis pathway and sequestering lysosomes into its para-
sitophorous vacuole [40-42]. Although the proteins
responsible for cholesterol acquisition in T. gondii have
not been identified, it is likely that they are also localized
to the parasitophorous membrane [40-42]. Thus, both P.Malaria Journal 2008, 7:211 http://www.malariajournal.com/content/7/1/211
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falciparum  and  Toxoplasma gondii might have similar
mechanisms of nutrient acquisition from the host cell.
Other interactions between P. falciparum and human pro-
teins that may shed light on parasite invasion and other
processes were identified in this study. For example, in a
screen against the liver human library, an interaction was
observed between a fragment of P. falciparum EXP-1
(PF11_0224) and overlapping fragments of human Pro-
grammed Cell Death 6-Interacting protein (PDCD6IP, or
ALIX) (Additional file 1). This interaction was shown to
be reproducible and specific by yeast two-hybrid (data not
shown). EXP-1 is a well-characterized integral membrane
protein localized to the parasitophorous vacuole [43,44].
PDCD6IP/ALIX is a class E vacuolar sorting protein
involved in the transport of cargo proteins by the multive-
sicular body for incorporation into intralumenal vesicles;
fusion between endosomes and the vacuole results in the
localization of cargo proteins to the vacuolar lumen [45].
In addition, PDCD6IP/ALIX is used by several viruses,
including HIV-1, for exiting infected cells [46]. Although
the interaction was identified in the high-throughput
screens against the liver library, EXP-1 is also expressed in
blood stages, and PDCD6IP/ALIX has been found by mass
spectrometry in the cytoplasm of the erythrocyte [47], sug-
gesting that the interaction could take place in either the
hepatocyte or the erythrocyte. It is possible that this inter-
action is involved in acquisition of vesicle contents by the
parasite.
Conclusion
More than 450 putative interactions between P. falciparum
proteins expressed during the intra-erythrocytic cycle and
human proteins expressed in liver or cerebellum are pre-
sented. The interaction between P. falciparum PFE1590w,
an ETRAMP, and human apolipoproteins was further
studied, and a differential interaction between PFE1590w
and isoforms of ApoE that have been associated with dif-
ferent outcomes of malaria infection was observed. It is
likely that this dataset will include other interactions of
potential interest that will expand the understanding of
the interplay between the parasite and the human host
and may lead to the identification of potential vaccine
candidates and drug targets.
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